Suppr超能文献

趋化因子 N 端特征的不同贡献证明了与 CXCR4 和 CXCR3 相比,趋化因子具有不同的配体结合模式和偏向于激活 ACKR3/CXCR7 的特点。

Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.

机构信息

Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.

Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA.

出版信息

Br J Pharmacol. 2018 May;175(9):1419-1438. doi: 10.1111/bph.14132. Epub 2018 Mar 23.

Abstract

BACKGROUND AND PURPOSE

Chemokines and their receptors form an intricate interaction and signalling network that plays critical roles in various physiological and pathological cellular processes. The high promiscuity and apparent redundancy of this network makes probing individual chemokine/receptor interactions and functional effects, as well as targeting individual receptor axes for therapeutic applications, challenging. Despite poor sequence identity, the N-terminal regions of chemokines, which play a key role in their activity and selectivity, contain several conserved features. Thus far little is known regarding the molecular basis of their interactions with typical and atypical chemokine receptors or the conservation of their contributions across chemokine-receptor pairs.

EXPERIMENTAL APPROACH

We used a broad panel of chemokine variants and modified peptides derived from the N-terminal region of chemokines CXCL12, CXCL11 and vCCL2, to compare the contributions of various features to binding and activation of their shared receptors, the two typical, canonical G protein-signalling receptors, CXCR4 and CXCR3, as well as the atypical scavenger receptor CXCR7/ACKR3, which shows exclusively arrestin-dependent activity.

KEY RESULTS

We provide molecular insights into the plasticity of the ligand-binding pockets of these receptors, their chemokine binding modes and their activation mechanisms. Although the chemokine N-terminal region is a critical determinant, neither the most proximal residues nor the N-loop are essential for binding and activation of ACKR3, as distinct from binding and activation of CXCR4 and CXCR3.

CONCLUSION AND IMPLICATIONS

These results suggest a different interaction mechanism between this atypical receptor and its ligands and illustrate its strong propensity to activation.

摘要

背景与目的

趋化因子及其受体形成了一个复杂的相互作用和信号网络,在各种生理和病理细胞过程中发挥着关键作用。该网络的高度混杂性和明显的冗余性使得探测单个趋化因子/受体相互作用和功能效应,以及针对单个受体轴进行治疗应用,具有挑战性。尽管趋化因子的 N 端区域序列同一性较差,但在其活性和选择性中起着关键作用,包含几个保守特征。到目前为止,人们对它们与典型和非典型趋化因子受体相互作用的分子基础,以及它们在趋化因子-受体对中的贡献的保守性知之甚少。

实验方法

我们使用了广泛的趋化因子变体和源自趋化因子 CXCL12、CXCL11 和 vCCL2 的 N 端区域的修饰肽,来比较各种特征对其共享受体(两个典型的、经典的 G 蛋白信号转导受体,CXCR4 和 CXCR3,以及非典型的清道夫受体 CXCR7/ACKR3,其仅表现出依赖抑制蛋白的活性)的结合和激活的贡献。

主要结果

我们提供了这些受体配体结合口袋的可塑性、它们的趋化因子结合模式和激活机制的分子见解。尽管趋化因子 N 端区域是一个关键决定因素,但与 CXCR4 和 CXCR3 的结合和激活不同,对于 ACKR3 的结合和激活来说,最接近的残基和 N 环都不是必需的。

结论和意义

这些结果表明了这个非典型受体与其配体之间的不同相互作用机制,并说明了它强烈的激活倾向。

相似文献

2
Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
J Biol Chem. 2017 Jan 6;292(1):31-42. doi: 10.1074/jbc.M116.762252. Epub 2016 Nov 14.
4
Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
J Leukoc Biol. 2020 Jun;107(6):1123-1135. doi: 10.1002/JLB.2MA0320-383RR. Epub 2020 May 6.
5
Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
Cytokine Growth Factor Rev. 2013 Feb;24(1):41-9. doi: 10.1016/j.cytogfr.2012.08.007. Epub 2012 Sep 16.
8
Characterization of a chimeric chemokine as a specific ligand for ACKR3.
J Leukoc Biol. 2018 Aug;104(2):391-400. doi: 10.1002/JLB.2MA1217-509R. Epub 2018 Mar 30.
10
Imaging ligand-dependent activation of CXCR7.
Neoplasia. 2009 Oct;11(10):1022-35. doi: 10.1593/neo.09724.

引用本文的文献

2
GPR15LG binds CXCR4 and synergistically modulates CXCL12-induced cell signaling and migration.
Cell Commun Signal. 2025 May 20;23(1):234. doi: 10.1186/s12964-025-02231-x.
3
Encoding and decoding selectivity and promiscuity in the human chemokine-GPCR interaction network.
Cell. 2025 Jun 26;188(13):3603-3622.e27. doi: 10.1016/j.cell.2025.03.046. Epub 2025 Apr 23.
5
Multiplex Detection of Fluorescent Chemokine Binding to CXC Chemokine Receptors by NanoBRET.
Int J Mol Sci. 2024 May 4;25(9):5018. doi: 10.3390/ijms25095018.
6
GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity.
Front Immunol. 2023 Jul 24;14:1242531. doi: 10.3389/fimmu.2023.1242531. eCollection 2023.
7
Reassessing the adrenomedullin scavenging function of ACKR3 in lymphatic endothelial cells.
PLoS One. 2023 May 30;18(5):e0285597. doi: 10.1371/journal.pone.0285597. eCollection 2023.
8
Computational design of dynamic receptor-peptide signaling complexes applied to chemotaxis.
Nat Commun. 2023 May 19;14(1):2875. doi: 10.1038/s41467-023-38491-9.
9
New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.
Front Immunol. 2023 Apr 20;14:1133394. doi: 10.3389/fimmu.2023.1133394. eCollection 2023.

本文引用的文献

2
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors.
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S17-S129. doi: 10.1111/bph.13878.
3
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S272-S359. doi: 10.1111/bph.13877.
6
Structural basis of ligand interaction with atypical chemokine receptor 3.
Nat Commun. 2017 Jan 18;8:14135. doi: 10.1038/ncomms14135.
7
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
Nature. 2016 Dec 15;540(7633):458-461. doi: 10.1038/nature20605. Epub 2016 Dec 7.
8
Intracellular allosteric antagonism of the CCR9 receptor.
Nature. 2016 Dec 15;540(7633):462-465. doi: 10.1038/nature20606. Epub 2016 Dec 7.
9
Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
J Biol Chem. 2017 Jan 6;292(1):31-42. doi: 10.1074/jbc.M116.762252. Epub 2016 Nov 14.
10
Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
Biochem Pharmacol. 2016 Aug 15;114:14-21. doi: 10.1016/j.bcp.2016.05.012. Epub 2016 May 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验